(ANN ARBOR, Mich.) Swift Biosciences today announced the availability of its eagerly anticipated Normalase™ Kit, a revolutionary enzymatic library normalization product that streamlines the cumbersome steps following next-generation sequencing (NGS) library preparation. Compared to conventional normalization, Swift Normalase saves cost on sequencing by reducing read depth variation within a pool down to a coefficient of variation […]
On November 26, 2018, China National GeneBank (CNGB) and BGI Research and the Macquarie University of Australia formally signed a cooperation agreement during the 7th International Yeast 2.0 and Synthetic Genomes Conference 2018 in Sydney, Australia. The two sides will jointly promote scientific research and education in synthetic biology, and focus on scientific research cooperation in natural products synthesisand […]
Agency to use Byos™ Platform for LC-MS MAM Studies CUPERTINO, CALIF. Protein Metrics Inc., a leading provider of mass spectrometry software for protein characterization, announced today it has received an FDA RFQ award to use its Byos™ platform for LC-MS multi-attribute method (MAM) analysis of protein therapeutics. “We are thrilled that the FDA has chosen […]
We are unveiling our new Sample to Insight QIAact Myeloid DNA UMI Panel at the American Society of Hematology (ASH) 60th Annual Meeting and Exposition held December 1-4, 2018, in San Diego, California. Stop by booth #1557 at ASH to explore our complete Sample to Insight solution for interrogating 25 genes for variants with known significance to clonal myeloid malignancies. Coupled […]
Genomenon announced that it has published the first Cited Variant Reference (CVR), a comprehensive catalogue of genetic variants cited in the medical literature. The term “variant” refers to a genomic mutation in the DNA – key data used in searching for causes of cancer and rare diseases. This first-in-kind Cited Variant Reference contains over 3.7 million […]
Cambridge, UK – Fluidic Analytics Ltd has raised $31 million to continue developing its transformational products for characterising proteins and their behaviour. The proceeds of the financing will be used to continue the commercial roll-out of the company’s lab-tools pipeline and to develop further high-value clinical applications of its technology. Proteins and their behaviour are crucial […]
SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the appointment of Jan Johannessen to the company’s board of directors. He will also serve as chair of the audit committee. Mr. Johannessen brings more than 25 years of executive and financial leadership experience […]
Today, LGC announced the acquisition of SeraCare Life Sciences, Inc., a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories. SeraCare provides quality control materials for infectious disease testing through their ACCURUN® reagents as well as in the fast growing clinical next-generation sequencing (NGS) market which it addresses through its Seraseq® brand of […]
Chicago, IL – Linden Capital Partners (“Linden”), a Chicago-based healthcare private equity firm, announced the sale of SeraCare Life Sciences (“SeraCare” or the “Company”) to LGC North America Inc. (“LGC”), a portfolio company of KKR & Co. Inc. SeraCare, a portfolio company of Linden Capital Partners, is a developer and manufacturer of biological products used […]
THOROLD, ON Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on nucleic acid and protein stabilization and purification, as well as providing high quality services to the scientific community, today announced that it has become Propel-Certified through Illumina as a Next Generation Sequencing (NGS) service provider. Norgen’s Propel Certification covers both […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
